The American Journal of Medicine
Volume 102, Issue 3 , Pages 232-238 , March 1997

Cocaine effects on digital blood flow and diffusing capacity for carbon monoxide among chronic cocaine users

    MB, ChB
  • John T. Sullivan

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Dr. J.T. Sullivan, Bayer Corporation, 400 Morgan Lane, West Haven, Connecticut 06516.
    • From the Departments of Medicine, Psychiatry, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA
    • , MD
  • Patrice M. Becker

      Affiliations

    • From the Departments of Medicine, Psychiatry, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA
    • , PhD
  • Kenzie L. Preston

      Affiliations

    • From the Behavioral Sciences, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA
    • , MD
  • Robert A. Wise

      Affiliations

    • From the Departments of Medicine, Psychiatry, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA
    • , MD
  • Frederick M. Wigely

      Affiliations

    • From the Departments of Medicine, Psychiatry, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA
    • , RN, MS
  • Margaret P. Testa

      Affiliations

    • From the Departments of Medicine, Psychiatry, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA
    • , MD
  • Donald R. Jasinski

      Affiliations

    • From the Departments of Medicine, Psychiatry, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA

Received 10 October 1995 ,Revised 18 November 1996

References 

  1. Benowitz NL. Clinical pharmacology and toxicology of cocaine. Pharmacol Toxicol. 1993;72:3–12
  2. Boehrer JD, Moliterno DJ, Willard JE, et al. Hemodynamic effects of intranasal cocaine in humans. J Am Coll Cardiol. 1992;20:90–93
  3. Preston KL, Sullivan JT, Strain EC, Bigelow GE. Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. J Pharmacol Exp Ther. 1992;262:279–291
  4. Gawin FH, Ellinwood EH. Cocaine, other stimulants. Actions, abuse and treatment. NEJM. 1988;318:1173–1182
  5. Jaffe JE. Drug addiction and drug abuse. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P editor. The Pharmacologic Basis of Therapeutics. 8th ed. New York: Pergamon Press; 1990;p. 522–573
  6. Somlyo AP, Somlyo AV. Vascular smooth muscle. II. Pharmacology of normal and hypertensive vessels. Pharmacological Reviews. 1970;22:249–349
  7. Wise RA. Neural mechanisms of the reinforcing action of cocaine. In: Grabowski J editors. Cocaine: Pharmacology, Effects, and Treatment of Abuse. National Institute of Drug Abuse Research Monograph 50. DHHS Pub. No. (ADM)87- 1326. Washington DC: SUPT. of Docs., US Govt Print Off; 1984;p. 15–33
  8. Knuepfer MM, Branch CA, Fisher VW. Mechanisms of cardiac and vascular responses to cocaine. In: Thadani P editors. Cardiovascular Toxicity of Cocaine: Underlying Mechanisms. National Institute of Drug Abuse Research Monograph 108. DHHS Pub. No. (ADM)91-1767. Washington DC: SUPT. of Docs., US Govt Print Off; 1991;p. 55–73
  9. Lange RA, Cigarroa RG, Yancy CW, et al. Cocaine-induced coronary artery vasoconstriction. NEJM. 1989;321:1557–1562
  10. London ED, Cascalla NG, Wong DF, et al. Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18] fluorodeoxyglucose. Arch Gen Psychiatry. 1990;47:567–574
  11. Pearlson GD, Jeffery PJ, Harris GJ, et al. Correlation of acute cocaineinduced changes in local cerebral blood flow with subjective effects. Am J Psychiatry. 1993;150:495–497
  12. Cregler LL, Mark H. Medical complications of cocaine abuse. NEJM. 1986;315:1495–1500
  13. Murray RJ, Smialek JE, Golle M, Albin RJ. Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization. Chest. 1989;96:1050–1053
  14. Overland ES, Nolan AJ, Haperwell PC. Alteration of pulmonary function in intravenous drug abusers. Am J Med. 1980;68:231–237
  15. Itkonen J, Schnoll S, Glassroth J. Pulmonary dysfunction in “freebase” cocaine users. Arch Intern Med. 1984;144:2195–2197
  16. Tashkin DP, Gorelick D, Khalsa ME, et al. Respiratory effects of cocaine freebasing among habitual cocaine users. J Addictive Diseases. 1992;11:59–70
  17. Weiss RD, Tilles DS, Goldenheim PD, Mirin SM. Decreased single breath carbon monoxide diffusing capacity in cocaine freebase smokers. Drug Alcohol Dependence. 1987;19:271–276
  18. Preston KL, Sullivan JT, Berger P, Bigelow GE. Effects of cocaine alone and in combination with mazindol in human cocaine abusers. J Pharmacol Exp Ther. 1993;267:296–307
  19. Boccalon HJ, Marguery MC, Ginestet MC, Puel PF. Laser doppler flowmeter and standardized thermal test in normals and Raynaud's phenomenon. Int Angiol. 1987;6:107–118
  20. Wigley FM, Wise RA, Mikdashi J, et al. The post-occlusive hyperemic response in patients with systemic sclerosis. Arthritis Rheum. 1990;33:1620–1625
  21. Jasinski DR, Sullivan JT, Cone E, et al. Pharmacodynamic and pharmacokinetic comparison of subcutaneously (sc) and intravenously (iv) given cocaine. Clin Pharmacol Ther. 1993;53:174
  22. American Thoracic Society . Single breath carbon monoxide diffusing capacity (Transfer Factor): Recommendations for a standard technique. Am Rev Resp Dis. 1987;136:1299–1307
  23. Cochran WG, Cox GM. In: 2nd ed. Experimental Designs. New York: John Wiley and Sons, Inc; 1957;
  24. Noe DA, Kumor KM. A pharmacokinetic-pharmacodynamic model of heart rate during cocaine administration in humans. Clin Pharmacol Ther. 1991;49:426–432
  25. Brogan WC, Lange RA, Glamann DB, Hillis LD. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med. 1992;116:556–561
  26. Snedecor GW. In: 5th ed. Statistical Methods. Ames, Iowa: The Iowa State University Press; 1956;
  27. Hamm LF, Stull GA, Crow RS. Exercise testing early after myocardial infarction: historic perspective and current uses. Prog Cardiovasc Dis. 1986;28:463–476
  28. Andrews HP, Snee RD, Sarner MN. Graphical display of means. Am Statistician. 1980;34:195–199
  29. Chow MJ, Ambre JJ, Ruo T, et al. Kinetics of cocaine distribution, elimination, and chronotropic effects. Clin Pharmacol Ther. 1985;38:318–324
  30. Fischman MW, Schuster CR, Resnekov L, et al. Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry. 1976;33:983–989
  31. Kumor K, Sherer M, Thompson L, et al. Lack of cardiovascular tolerance during intravenous cocaine infusion in human volunteers. Life Sci. 1988;42:2063–2071
  32. Jacobsen TN, Snyder RW, Grayburn PA, et al. Intranasal cocaine decreases sympathetic nerve activity in humans. Circulation. 1993;88:1–85
  33. Shannon RP, Manders WT, Shen YT. Role of blood doping in the coronary vasoconstrictor response to cocaine. Circulation. 1995;92:96–105
  34. Budney AJ, Higgins ST, Hughes JR, Bickel WK. Nicotine and caffeine use in cocaine-dependent individuals. J Substance Abuse. 1993;5:117–130

** This research was supported by United States Public Health Service research grants DA 06120 & 5 MO1 RR02719.

PII: S0002-9343(96)00453-6

doi: 10.1016/S0002-9343(96)00453-6

The American Journal of Medicine
Volume 102, Issue 3 , Pages 232-238 , March 1997

Article Tools